Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Favira vs Avigan in Healthy Subjects
NCT04651959Phase 1Unknown
- Start
- Nov 2020
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of favipiravir in influenza (2 arms). Primary endpoints: Favipiravir Area Under the Curve from time 0 to the last measurable concentration and Favipiravir Maximum Plasma Concentration. Status: unknown.
02
Drugs
favipiravir
03
Conditions
influenza
Beyond the preview
Go deeper on NCT04651959.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04651959.